In the context of ovarian cancer, Han et al., have developed a liposome conjugated with a recombinant protein, EC1-GLuc, fusion of EC1 peptide, an artificial ligand of HER2, with Gaussia luciferase (GLuc) for bioluminescent imaging (34). This evidence concerns the gene ERBB2 and ovarian carcinoma.